Skip to main content
Texas Life Science Forum
  • BioHouston
  • Rice Alliance
  • News
  • Agenda
  • Speakers
  • Participating Ventures
  • Investors
  • Sponsors
  • Testimonials
Texas Life Science Forum
  • Agenda
  • Speakers
  • Participating Ventures
  • Investors
  • Sponsors
  • Testimonials
  • BioHouston
  • Rice Alliance
  • News

Enter a Search Term

Hein, Sarah

Sarah Hein, Ph.D.

CEO, March Biosciences

Hein, Sarah

Sarah is the founding CEO of March Biosciences, a clinical-stage cell-therapy company targeting challenging hematological malignancies. Prior to cofounding March Bio, she was the founding Entrepreneur in Residence for the Texas Medical Center Innovation Accelerator for Cancer Therapeutics (TMCi ACT). Formerly, she was a cofounder and the Vice President of Operations at Courier Therapeutics, a cancer immunotherapy startup acquired by Valo Health. She was also Director of Research at Resonant Therapeutics, an antibody therapeutics platform technology company. She began at Mercury Fund as a Venture Fellow directly after graduating with her PhD in Molecular Biology from Baylor College of Medicine.

Site Footer

Rice Alliance
BIO HOUSTON: Building the Life Science Future

Follow Us

  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

Footer

  • 2022 Feb Companies
  • 2022 February TLSF Speakers
  • 2022 February TLSF

Contact us:

Ann Tanabe, BioHouston
Tara Williams, Rice Alliance

Copyright © 2022 Jesse H. Jones Graduate School of Business, Rice University

Privacy Notice

  • BioHouston
  • Rice Alliance